IPP Bureau

Ichnos Sciences inks agreement with Astria Therapeutics for OX40 antagonist monoclonal antibody portfolio
Ichnos Sciences inks agreement with Astria Therapeutics for OX40 antagonist monoclonal antibody portfolio

By IPP Bureau - October 13, 2023

Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications

IMI 5.0 campaign with special focus on improvement of Measles and Rubella vaccination coverage
IMI 5.0 campaign with special focus on improvement of Measles and Rubella vaccination coverage

By IPP Bureau - October 13, 2023

Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country

GlobalData predicts product cannibalization within electrophysiology ablation space
GlobalData predicts product cannibalization within electrophysiology ablation space

By IPP Bureau - October 12, 2023

PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm

Allergan’s conclave on World Sight Day spotlights eyecare's crucial role in workplace
Allergan’s conclave on World Sight Day spotlights eyecare's crucial role in workplace

By IPP Bureau - October 12, 2023

India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness

Mandaviya inaugurates new facilities at NIMHANS and launches new logo of Tele-MANAS
Mandaviya inaugurates new facilities at NIMHANS and launches new logo of Tele-MANAS

By IPP Bureau - October 11, 2023

Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells

Ayurveda benefits animal, plant and human life, says Sonowal
Ayurveda benefits animal, plant and human life, says Sonowal

By IPP Bureau - October 11, 2023

Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush

Eni and Dompe farmaceutici join forces for health research
Eni and Dompe farmaceutici join forces for health research

By IPP Bureau - October 11, 2023

Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer

AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 billion sales by 2029, says GlobalData
AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 billion sales by 2029, says GlobalData

By IPP Bureau - October 11, 2023

Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio

Philips and World Stroke Organization partner to improve access to high-quality stroke care
Philips and World Stroke Organization partner to improve access to high-quality stroke care

By IPP Bureau - October 11, 2023

Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge

Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for 3D printed medical implants
Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for 3D printed medical implants

By IPP Bureau - October 11, 2023

Alignment of carbon-fiber can be controlled during the 3D printing process

Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan
Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan

By IPP Bureau - October 11, 2023

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients

Sun Pharma gets USFDA filing acceptance of new drug application for Deuruxolitinib
Sun Pharma gets USFDA filing acceptance of new drug application for Deuruxolitinib

By IPP Bureau - October 09, 2023

The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials

Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America
Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America

By IPP Bureau - October 09, 2023

American Oncology Institute launched Bone Marrow Transplant programs in India
American Oncology Institute launched Bone Marrow Transplant programs in India

By IPP Bureau - October 09, 2023

Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services

Dozee unveils ‘Dozee Pro Ex’ for seamless continuum of monitoring from hospital to home
Dozee unveils ‘Dozee Pro Ex’ for seamless continuum of monitoring from hospital to home

By IPP Bureau - October 09, 2023

Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings

Latest Stories

Interviews

Packaging